The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, June 30, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 29, 2020 the Company sold 42 000 own shares representing 0.0312% of the share capital of the Company, at a total value of BGN 132 300 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.
The total number of treasury shares after this transaction is 8 986 467, representing 6.667% of the share capital of the Company.
Sofia, Bulgaria, June 29, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 26, 2020 the Company sold 15 000 own shares representing 0.0111% of the share capital of the Company, at a total value of BGN 47 250 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.
The total number of treasury shares after this transaction is 9 028 467, representing 6.698% of the share capital of the Company.
Sofia, Bulgaria, June 26, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 25, 2020 the Company sold 10 000 own shares representing 0.0074% of the share capital of the Company, at a total value of BGN 31 500 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.
The total number of treasury shares after this transaction is 9 043 467, representing 6.709% of the share capital of the Company.
Sofia, Bulgaria, June 25, 2020 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on June 24, 2020 the Company sold 5 000 own shares representing 0.0037% of the share capital of the Company, at a total value of BGN 15 750 on the Bulgarian Stock Exchange, the average price per share was 3.1500 BGN.
The total number of treasury shares after this transaction is 9 053 467, representing 6.716% of the share capital of the Company.